In short
Thyrocare Technologies Limited (THYROCARE.NS) has revenue up 20.7% to INR 8.2B and net income up 78.2% to INR 1.6B year on year. Its net margin is 19.8% and gross margin 73.3%, and it trades at 45.2× trailing earnings. Fisclear found no medium- or high-severity risk flags in this filing. How we calculate this
Valuation
HealthcareLive · Yahoo FinancePrice
₹499.70
₹79.5B
29.9x
1.87%
52-Week Range
4-engine score — Quality and Peers engines require SEC EDGAR (US stocks only)
ROE 27.8% — exceptional capital return.
P/E 45.3× — premium valuation.
Revenue growing 21% YoY.
Based on filing period ending Mar 2026
International FisclearScore uses 4 engines (no EDGAR data). Based on Yahoo Finance & Alpha Vantage reported financials. Not financial advice.
🇮🇳 India Macro Indicators
Full dashboard →Policy Rate
6.75%↑
Restrictive
USD/INR
95.449→
The India central bank policy rate stands at 6.75% — a restrictive rate environment; USD/INR is at 95.449.
SWOT Analysis — THYROCARE.NS
Inflationary BoomStrengths
Net Income: INR 1.6B (+78.2% YoY) — Profit grew 78% — the company kept more of each dollar earned.
EPS (Diluted): INR 10.21 (+78.1% YoY) — Earnings per share rose 78% — each share earned more.
Gross Profit: INR 6.0B (+23.0% YoY) — Gross profit rose 23% — the spread between revenue and direct costs improved.
Revenue: INR 8.2B (+20.7% YoY) — Revenue grew 21% — the company sold more goods or services than the prior year.
Operating Cash Flow: INR 2.1B (+18.5% YoY) — Operating cash flow grew 19% — the business generated more cash from day-to-day operations.
Weaknesses
No material weaknesses flagged.
Opportunities
No clear opportunities identified at this time.
Threats
No significant threats flagged.
Financial Charts
Year-over-Year Changes
Net Income
INR 1.6B
was INR 915.1M
Profit grew 78% — the company kept more of each dollar earned.
EPS (Diluted)
INR 10.21
was INR 5.74
Earnings per share rose 78% — each share earned more.
Gross Profit
INR 6.0B
was INR 4.9B
Gross profit rose 23% — the spread between revenue and direct costs improved.
Revenue
INR 8.2B
was INR 6.8B
Revenue grew 21% — the company sold more goods or services than the prior year.
Operating Cash Flow
INR 2.1B
was INR 1.8B
Operating cash flow grew 19% — the business generated more cash from day-to-day operations.
Price HistoryINR
Technical Signals
Daily closes · 1-year dataLatest News
via FinnhubGet the weekly digest
5 company reports + macro context every week, free. No spam.
- Unlimited goal simulations
- 5 free company report summaries per day
- Weekly financial insights newsletter
External Links
Research Thyrocare Technologies Limited
Data sourced from NSE India, FRED (Federal Reserve), OECD, BIS, and Yahoo Finance. For informational purposes only. Not financial advice.